Such transient hyperglycemia may be driven by inflammation and progressive immune response to disrupted MTB containment, with the release of tumour necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) causing both low insulin production and increased resistance and possible correlates with severity of TB disease [11–13]. This evidence concerns the gene IFNG and Hyperglycemia.